Dtsch Med Wochenschr 2015; 140(10): 756-760
DOI: 10.1055/s-0041-102222
Fachwissen
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Verhaltensbasierte Prävention chronischer Krankheiten – wie kann sie gelingen?

Behavior-based prevention of chronic diseases
Ulrich John
1   Universitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention
2   Deutsches Zentrum für Herz-Kreislauf-Forschung, Standort Greifswald
,
Sabina Ulbricht
1   Universitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention
2   Deutsches Zentrum für Herz-Kreislauf-Forschung, Standort Greifswald
,
Jennis Freyer-Adam
1   Universitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention
2   Deutsches Zentrum für Herz-Kreislauf-Forschung, Standort Greifswald
,
Christian Meyer
1   Universitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention
2   Deutsches Zentrum für Herz-Kreislauf-Forschung, Standort Greifswald
› Author Affiliations
Further Information

Publication History

Publication Date:
13 May 2015 (online)

Zusammenfassung

Hintergrund: Tabakrauchen, gesundheitsriskanter Alkoholkonsum, Übergewicht und Bewegungsmangel tragen zu mehr als 50 % von Herzinfarkten bei und bilden die häufigsten vermeidbaren Entstehungsfaktoren von Krebserkrankungen. Herz-Kreislauf- und Krebserkrankungen ließen sich verringern durch Prävention zusätzlich zur medizinischen Versorgung. Ziel dieses Beitrags ist die Elemente darzustellen, die Prävention ausmachen: Teilnehmerraten, Interventionsprogramme und Ergebnisse. Ergebnis-Kriterien umfassen die Intentionen zur Verhaltensänderung, die Verhaltensweisen selber, die gesamte Lebenszeit und die Zeit der Freiheit von chronischer Krankheit und Behinderung.

Ergebnisse: Der Stand internationaler Evidenz zeigt, dass Präventionsleistungen auf nationaler Ebene Umweltänderungen und direkte Interventionen umfassen sollten. Umweltänderungen beinhalten Reduktion der Attraktivität von und Schutz der Menschen vor gesundheitsriskanten Produkten. Direkte Intervention schließt besonders Beratungen ein. Diese Leistungen führen zu Reduktionen inzidenter Herz-Kreislauf- und Krebserkrankungen. Die Evidenz zur Wirksamkeit von Prävention stellen Verlaufsstudien, Modellrechnungen zu Risikofaktoren und Krankheiten sowie Kontrollgruppenstudien bereit. Alle drei Analyse-Ansätze belegen Erfolge der Prävention. Die Zusammenarbeit von Prävention und medizinischer Versorgung trägt zu Synergien bei.

Folgerung: Es besteht ein Handlungsdefizit. Bewährte oder als wirksam belegte Leistungen sollten in die Praxis umgesetzt, die Kooperation zwischen Prävention und medizinischer Versorgung gefördert werden.

Abstract

Background: Tobacco smoking, unhealthy alcohol drinking, overweight, and lack of physical activity add to more than 50 % of myocardial infarction and are the most prevalent avoidable factors related to cancer. Cardiovascular disease and cancer may be curbed by preventive action in addition to medical care. The aim of this contribution is to present the elements that constitute prevention: participation rates, intervention programs, and outcomes. Criteria for outcomes include intention to change behaviors, the behavior change, total lifetime and time of life free of chronic disease and disability.

Results: Evidence reveals that national preventive action should include legal action, environmental change, and direct health behavior change. The measures include reducing the appeal of and increasing the protection against risky products. Such provisions will reduce cardiovascular disease and cancer incidence. Direct behavior change includes counseling individuals in the general population. Evidence is provided by cohort, modeling, and controlled trial data. All three approaches revealed success of prevention. Collaboration of prevention and medical care will add to synergies.

Conclusion: A deficit of action exists. Effective preventive action should be implemented into practice, cooperation between prevention and medical care be supported.

 
  • Literatur

  • 1 McGinnis JM, Williams-Russo P, Knickman JR. The case for more active policy attention to health promotion. Health Aff 2002; 21: 78-93
  • 2 US Department of Health and Human Services. The health consequences of smoking – 50 years of progress. A report of the surgeon general. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014
  • 3 O’Flaherty M, Buchan I, Capewell S. Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960 s?. Heart 2013; 99: 159-162
  • 4 Jones DS, Greene JA. The contributions of prevention and treatment to the decline in cardiovascular mortality: lessons from a forty-year debate. Health Aff 2012; 31: 2250-2258
  • 5 Farrelly MC, Pechacek TF, Thomas KY, Nelson D. The impact of tobacco control programs on adult smoking. Am J Public Health 2008; 98: 304-309
  • 6 Warner KE, Mendez D, Alshanqeety O. Tobacco control success versus demographic destiny: examining the causes of the low smoking prevalence in California. Am J Public Health 2008; 98: 268-269
  • 7 Österberg E, Karlsson T editors. Alcohol policies in the EU member states and Norway. A collection of country reports. Helsinki: STAKES; 2002
  • 8 World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011
  • 9 Seitz HK, Bühringer G, Mann K. Grenzwerte für den Konsum alkoholischer Getränke: Empfehlungen des wissenschaftlichen Kuratoriums der DHS. In: Deutsche Hauptstelle für Suchtfragen e. V., Hrsg. Jahrbuch Sucht 08. Geesthacht: Neuland; 2008: 205-209
  • 10 World Health Organization. Obesity: Preventing and managing the global epidemic. Geneva: World Health Organization; 2000
  • 11 Vanhees L, De Sutter J, Gelada SN et al. Importance of characteristics and modalities of physical activity and exercise in defining the benefits to cardiovascular health within the general population: recommendations from the EACPR (Part I). Eur J Prevent Cardiol 2012; 19: 670-686
  • 12 Lloyd-Jones DM, Hong Y, Lebarthe D et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 2010; 121: 586-613
  • 13 Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952
  • 14 Colditz GA, Wei EK. Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health 2012; 33: 137-156
  • 15 Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011; 105 (Suppl. 02) S77-S81
  • 16 Ford ES, Greenlund KJ, Hong Y. Ideal cardiovascular health and mortality from all causes and diseases of the circulatory system among adults in the United States. Circulation 2012; 125: 987-995
  • 17 Kones R. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Ther Adv Cardiovasc Dis 2011; 5: 61-81
  • 18 Bellach BM, Knopf H, Thefeld W. Der Bundesgesundheitssurvey. Gesundheitswesen 1998; 60 (Suppl. 02) S59-S68
  • 19 Loef M, Walach H. The combined effects of healthy lifestyle behaviors on all cause mortality: a systematic review and meta-analysis. Prev Med 2012; 55: 163-170
  • 20 Chakravarty EF, Hubert HB, Krishnan E et al. Lifestyle risk factors predict disability and death in healthy aging adults. Am J Med 2012; 125: 190-197
  • 21 Ezzati M, Hoorn SV, Rodgers A et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003; 362: 271-280
  • 22 Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635-1701
  • 23 Di Chiara A, Vanuzzo D. Does surveillance impact on cardiovascular prevention?. Eur Heart J 2009; 30: 1027-1029
  • 24 Jorgensen T, Capewell S, Prescott E et al. Population-level changes to promote cardiovascular health. Eur J Prevent Cardiol 2013; 20: 409-421
  • 25 John U, Meyer C, Ulbricht S et al. Reduktion von Tabak- und Alkoholkonsum. In: Hoefert W, Klauer T, Hrsg. Krankheitsprävention in der Kontroverse. Lengerich: Pabst; 2014: 307-325
  • 26 Flay BR, Schure MB. The theory of triadic influence. In: Wagenaar AC, Burris S, (Hrsg.): Public Health Law Research. San Francisco: Jossey-Bass; 2013: 169-191
  • 27 Petras H, Sloboda Z. An integrated prevention science model: a conceptual foundation for prevention research. In: Sloboda Z, Petras H, (Hrsg.) Defining Prevention Science. New York: Springer; 2014: 251-273
  • 28 Gallo V, Mackenbach JP, Ezzati M et al. Social inequalities and mortality in Europe – results from a large multi-national cohort. PLoS One 2012; 7: e39013
  • 29 Wilkinson R, Pickett K. The Spirit level: Why more equal societies almost always do better. London: Penguin; 2009
  • 30 Wagenaar AC, Burris S (eds). Public Health Law Research. San Francisco: Jossey-Bass; 2013
  • 31 Webb TL, Sniehotta FF, Michie S. Using theories of behaviour change to inform interventions for addictive behaviours. Addiction 2010; 105: 1879-1892
  • 32 John U, Meyer C, Rumpf H-J, Hapke U. Relation among stage of change, demographic characteristics, smoking history, and nicotine dependence in an adult German population. Prev Med 2003; 37: 368-374
  • 33 Meyer C, Ulbricht S, Gross B et al. Adoption, reach and effectiveness of computer-based, practitioner delivered and combined smoking interventions in general medical practices: A three-arm cluster randomized trial. Drug Alcohol Depend 2012; 121: 124-132
  • 34 Bischof G, Grothues J, Reinhardt S et al. Evaluation of a telephone-based stepped care intervention for alcohol-related disorders: a randomized controlled trial. Drug Alcohol Depend 2008; 93: 244-251
  • 35 Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol 2005; 1: 91-111
  • 36 Goff Jr DC, Lloyd-Jones DM, Bennett G et al. 2013 ACC / AHA guideline on the assessment of cardiovascular risk. Circulation 2014; 129, 25 (Suppl. 02) S49-S73
  • 37 Kurz-Milcke E, Gigerenzer G, Martignon L. Transparency in risk communication: graphical and analog tools. Ann N Y Acad Sci 2008; 1128: 18-28
  • 38 Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999; 89: 1322-1327
  • 39 Yusuf S, Rangarajan S, Teo K et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 2014; 371: 818-827
  • 40 World Health Organization. Scaling up action against noncommunicable diseases: How much will it cost?. Geneva: World Health Organization; 2011